Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC). Nagasaka M, Asad MFB, Al Hallak MN, Uddin MH, et al. Lung Cancer 2021;160:92-98.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nagasaka M, Asad MFB, Al Hallak MN, Uddin MH, et al. Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC). Lung Cancer 2021;160:92-98.
PMID: 34482103